Panels

Each Panel consists of 5 - 8 international experts looking at the literature and answering specific questions. A short text will be submitted to the Jury before the Conference and the Panel Chair will present the data to the Jury and audience followed by Q/A.

Panel 1, 2, 3, 4 and 5 will focus on assessing outcome from different perspectives, called Stake-holders perspectives. Panel 6 will focus on benchmarking techniques for the results of medical interventions. Panel 7 will put a special attention on high-risk patients. Panel 8 targets practical implication of outcome research or how to integrate outcome parameters in decision making, and Panel 9 will look at diversity and how to adjust relevant outcome parameters regarding gender and demo-graphic differences.

More detailed information and the respective questions of the individual Panels can be found below.

Panel 1

Panel Chair: Christoph A. Meier – Professor and Chairman, Department of Internal Medicine, University Hospital of Zurich, Switzerland

Outcomes after surgical and medical intervention from a Patient perspective

  • Which patient reported outcome should be used in clinical practice and in research?
  • Which outcomes are typically not represented in PROMs, and which should they be incorporated? (Return to work, out of pocket cost, burden for family)
  • How important are PREMs? (Including time spent with patient, trust in care-team)

Panel Members:

S. Webb

L. Bloom

J. Deerberg Wittram

M. Pomey

F. Rüter

F. VanHove-Bismuth

E. Zimlichman

Panel 2

Panel Chair: Han-Kwang Yang – Director of Seoul National University Hospital Cancer Hospital, Seoul, Korea

Outcomes after Surgical and Medical Interventions from a Health Care Provider Perspective (Doctor, Nurses)

  • How can complications data be recorded and audited?
  • How should a satisfying patient-caregiver relationship be measured? (Time spent with patient, trust in doctor)
  • Which other outcomes should be reported and how?
  • How to use M&M conferences to improve patient outcomes?

Panel Members:

F. Berlth

M. S. deVos

H. Kelhet

P. Müller

J. Ramia

D. Raptis

K. A. Sienko

R. Staiger

Panel 3

Panel Chair: Thomas Szucs – Chairman of the Board Helsana, Switzerland

Outcomes after surgical and medical intervention from a Payer perspective

  • Is there a relation between cost and quality and how would you measure it?
  • How would you avoid unnecessary treatment?
  • Which cost-relevant outcomes should be reported to whom and how?
  • How would you measure the endpoints of value-based medicine?
  • Who is accountable for assessing outcome?

Panel Members:

M. Fey

S. O’Reilly

R. Vonlanthen

Y. Yamada

Panel 4

Panel Chair: Thomas Zeltner – Chairman WHO Foundation – Former Director General Federal Office of Public Health, Switzerland

Outcomes after surgical and medical intervention from a State/­Government/­Society perspective

  • What should be measured in outcomes to evaluate regulatory policies?
  • On the basis of what data should regulatory decisions be made?
  • How should outcomes influence regulatory policies? Which outcome should influence policies?
  • What outcome should indicate to decide whether to centralize more or less
  • What outcome could be used to measure differences in terms of outcomes in healthcare systems around the world?

Panel Members:

D. Birrer

A. Von Eschenbach

C. Ko

J. Lazarus

Z. Or

Panel 5

Panel Chair: Samia Hurst – Director of the Institute for Ethics University of Geneva – Member of the National committee of Ethics, Geneva, Switzerland

Outcomes after surgical and medical intervention from a legal and ethical perspective

  • What outcomes should be measured to assess outcome quality from a normative (ethical and legal) perspective?
  • How can we determine what a good, a bad, and/or an acceptable outcome is?
  • When something goes wrong, how can we determine the presence and degree of culpability?
  • What would be an ethically appropriate response to culpable mistakes?
  • What would be an ethically appropriate response to non culpable harms?
  • How to present the potential benefit and risks as basis for informed decision making

Panel Members:

C. Ho

M. Huber

J. Ives

T. Krones

T. Sano

RD. Truog

S. Venkatapuram

Panel 6

Panel Chair: Jeffrey Barkun – Professor of Surgery and Chief Medical Information Officer, McGill University Hospital, Montreal, Canada

Benchmarking of Surgical Procedures

  • What is the goal of “Benchmarking” in surgery and which techniques should be used?
  • Data quality considerations – develop database gold standards
  • How to communicate results of Benchmarking to surgeons and department heads?

Panel Members:

J. AbouKhalil

A. Domenghino

J. Fiore

C. Hincapie

N. Kokudo

T. Pawlik

Panel 7

Panel Chair: Mike Grocott; Professor of Anaesthesia and Critical Care Medicine, University of Southhampton, UK

High Risk patients

  • How to define «high risk» patients (for different procedures)
  • How to assess indication for surgical intervention in high-risk patients? (yes/no, how?)

Panel Members:

M. Adams

J. Armitage

J. Bartussek

J.-D. Chiche

D. A. Hofmänner

S. Jackson

M. Kalisvaart

M. Krauthammer

A. Lübbeke-Wolff

R. Moonesinghe

P. Sanchez-Velazquez

R. Schüpbach

A. Zientara

Panel 8

Panel Chair: Tanja Stamm – Professor and Head of Section for Outcomes Research, Wien, Austria

Public reporting of outcome data

  • Sharing patient outcomes (involving patients in medical decision making)
  • Auditing data integrity (statistical testing, adverse selection, case-mix)

Panel Members:

F. Abbassi

B. Elger

A. Joeris

F. Rothenfluh

F. Schneuwly

Y. Seidler

G. Sivaraman

Panel 9

Panel Chair: Betsy Tuttle – MD MHA FACS, Chair and Chief of Surgery, East Carolina University/Vidant Health, North Carolina, USA

Consideration of cultural and demographic differences in outcome interpretation

  • How should selection and interpretation of surgical outcomes differ depending on cultural and demographic factors?

Panel Members:

T. Ballouz

A. Costa-Ramón

P. Jin

R. Snyder

M. Tyebally Feng

C. Witt